Literature DB >> 12525271

Antidepressants in the treatment of migraine headache.

Nestor C Punay1, James R Couch.   

Abstract

Antidepressants, particularly tricyclic antidepressants, have been a mainstay in the prophylactic therapy of migraine. The tricyclic antidepressants amitriptyline, nortriptyline, and doxepin have been the major agents for prophylactic treatment of migraine. These cause significant side effects in some patients. The high-affinity selective serotonin reuptake inhibitors and other newer antidepressants have been disappointing and much less effective in the treatment of migraine. In patients who are depressed with severe migraine, a tricyclic antidepressant may treat both conditions; however, the addition of a newer atypical antidepressant may be needed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525271     DOI: 10.1007/s11916-003-0010-8

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  37 in total

1.  Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S D Silberstein
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

Review 2.  Migraine prophylactic drugs: proof of efficacy, utilization and cost.

Authors:  N M Ramadan; L L Schultz; S J Gilkey
Journal:  Cephalalgia       Date:  1997-04       Impact factor: 6.292

3.  Doxepin in the prophylactic treatment of mixed 'vascular' and tension headache.

Authors:  T J Mørland; O V Storli; T E Mogstad
Journal:  Headache       Date:  1979-11       Impact factor: 5.887

4.  Trazodone and intractable headaches.

Authors:  R Pies
Journal:  J Clin Psychiatry       Date:  1983-08       Impact factor: 4.384

5.  Nefazodone for chronic daily headache prophylaxis: an open-label study.

Authors:  J R Saper; A E Lake; S J Tepper
Journal:  Headache       Date:  2001-05       Impact factor: 5.887

6.  A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis.

Authors:  J Bánk
Journal:  Headache       Date:  1994-09       Impact factor: 5.887

7.  Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazine.

Authors:  T D Brewerton; D L Murphy; E A Mueller; D C Jimerson
Journal:  Clin Pharmacol Ther       Date:  1988-06       Impact factor: 6.875

8.  Joint 1994 Wolff Award Presentation. Migraine and major depression: a longitudinal study.

Authors:  N Breslau; G C Davis; L R Schultz; E L Peterson
Journal:  Headache       Date:  1994 Jul-Aug       Impact factor: 5.887

9.  Migraine prophylaxis. A comparison of propranolol and amitriptyline.

Authors:  D K Ziegler; A Hurwitz; R S Hassanein; H A Kodanaz; S H Preskorn; J Mason
Journal:  Arch Neurol       Date:  1987-05

Review 10.  Hypothesis: serotonin-1C receptor activation in migraine: an alternative point of view with therapeutic implication.

Authors:  E L Spierings
Journal:  Headache       Date:  1991-09       Impact factor: 5.887

View more
  12 in total

Review 1.  Practical considerations for the treatment of elderly patients with migraine.

Authors:  Paola Sarchielli; Maria Luisa Mancini; Paolo Calabresi
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  The pharmacological management of migraine, part 2: preventative therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-08

3.  PHARMACOLOGICAL TREATMENTS FOR TINNITUS: NEW AND OLD.

Authors:  R Salvi; E Lobarinas; W Sun
Journal:  Drugs Future       Date:  2009       Impact factor: 0.148

Review 4.  Prophylactic Treatment of Migraine.

Authors:  Azize Esra Gürsoy; Mustafa Ertaş
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

5.  Persistent orthostatic headache without intracranial hypotension: which treatment?

Authors:  M Curone; A Proietti Cecchini; L Chiapparini; D D'Amico
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

6.  Outcome of patients with chronic migraine with medication overuse and depression after duloxetine: influence of coexisting obsessive compulsive disorder.

Authors:  Marcella Curone; V Tullo; M Savino; A Proietti-Cecchini; G Bussone; D D'Amico
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

Review 7.  [A clinical challenge. Pragmatic treatment of migraine and concomitant depression].

Authors:  T P Jürgens; E Leinisch; H J Koch
Journal:  Schmerz       Date:  2008-02       Impact factor: 1.107

Review 8.  Antidepressants in long-term migraine prevention.

Authors:  Horst J Koch; Tim P Jürgens
Journal:  Drugs       Date:  2009       Impact factor: 9.546

9.  Concomitant medication of psychoses in a lifetime perspective.

Authors:  Maria Vares; Peter Saetre; Pontus Strålin; Sten Levander; Eva Lindström; Erik G Jönsson
Journal:  Hum Psychopharmacol       Date:  2011-06-22       Impact factor: 1.672

10.  Italian guidelines for primary headaches: 2012 revised version.

Authors:  Paola Sarchielli; Franco Granella; Maria Pia Prudenzano; Luigi Alberto Pini; Vincenzo Guidetti; Giorgio Bono; Lorenzo Pinessi; Massimo Alessandri; Fabio Antonaci; Marcello Fanciullacci; Anna Ferrari; Mario Guazzelli; Giuseppe Nappi; Grazia Sances; Giorgio Sandrini; Lidia Savi; Cristina Tassorelli; Giorgio Zanchin
Journal:  J Headache Pain       Date:  2012-05       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.